Evaluation of MLN4924, an investigational NEDD8-activating enzyme (NAE) inhibitor, as a novel targeted agent with single-agent antitumor activity in mantle cell lymphoma (MCL) and Hodgkin lymphoma preclinical models.
Richa Dawar
No relevant relationships to disclose
Matthew John Barth
No relevant relationships to disclose
Cory Mavis
No relevant relationships to disclose
Jospeh J. Skitzki
No relevant relationships to disclose
Myron Stefan Czuczman
Consultant or Advisory Role - Millennium
Honoraria - Millennium
Pavel Klener
No relevant relationships to disclose
Francisco J. Hernandez-Ilizaliturri
No relevant relationships to disclose